IRIS - Res&Arch Institutional Research Information System - Research & Archive

MENCARELLI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.581
EU - Europa 1.910
AS - Asia 1.028
SA - Sud America 207
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 5.741
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.558
UA - Ucraina 413
IE - Irlanda 400
SG - Singapore 399
HK - Hong Kong 251
RU - Federazione Russa 225
SE - Svezia 217
IT - Italia 214
BR - Brasile 188
VN - Vietnam 144
FI - Finlandia 133
DE - Germania 130
CN - Cina 118
TR - Turchia 54
FR - Francia 50
GB - Regno Unito 32
KR - Corea 22
RO - Romania 19
CH - Svizzera 18
CZ - Repubblica Ceca 16
CA - Canada 10
MX - Messico 10
BE - Belgio 8
EC - Ecuador 8
AT - Austria 7
IN - India 7
PL - Polonia 7
UZ - Uzbekistan 7
GR - Grecia 6
NL - Olanda 6
ES - Italia 5
EU - Europa 5
AR - Argentina 4
KG - Kirghizistan 4
LB - Libano 4
BD - Bangladesh 3
CO - Colombia 3
IQ - Iraq 3
KE - Kenya 3
BN - Brunei Darussalam 2
DK - Danimarca 2
JO - Giordania 2
MA - Marocco 2
PA - Panama 2
PK - Pakistan 2
VE - Venezuela 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BB - Barbados 1
CL - Cile 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
HU - Ungheria 1
JP - Giappone 1
KZ - Kazakistan 1
LT - Lituania 1
MN - Mongolia 1
NP - Nepal 1
PY - Paraguay 1
Totale 5.741
Salva come PNG Salva come JPEG
Città #
Chandler 481
Dublin 400
Singapore 271
Hong Kong 251
San Mateo 224
Jacksonville 190
Wilmington 149
Dong Ket 144
Boardman 136
Altamura 119
Santa Clara 110
Medford 100
Princeton 100
Lawrence 84
Moscow 74
Andover 69
Ann Arbor 66
Perugia 58
Beijing 47
Izmir 46
Ashburn 44
Des Moines 42
Falls Church 35
Saint Petersburg 28
Columbus 27
Helsinki 22
New York 22
Los Angeles 20
Norwalk 17
São Paulo 15
San Paolo di Civitate 14
Timisoara 13
Turku 13
Munich 11
Seoul 11
Woodbridge 11
Olomouc 10
Rio de Janeiro 10
Brussels 8
Ottawa 8
Phoenix 8
Shanghai 7
Belo Horizonte 6
Bucharest 6
Dearborn 6
The Dalles 6
Auburn Hills 5
Dallas 5
Houston 5
Bishkek 4
Charlotte 4
Curitiba 4
Guayaquil 4
Redwood City 4
San Francisco 4
Vienna 4
Americana 3
Ankara 3
Chennai 3
Contagem 3
Den Haag 3
Goiânia 3
Itajaí 3
Lausanne 3
London 3
Mexico City 3
Nairobi 3
Porto Alegre 3
Quito 3
Rovato 3
Stockholm 3
Tashkent 3
Amman 2
Antakya 2
Atlanta 2
Baghdad 2
Bandar Seri Begawan 2
Blumenau 2
Boston 2
Cabo Frio 2
Campinas 2
Caxias do Sul 2
Chicago 2
Florianópolis 2
Frankfurt Am Main 2
Guangzhou 2
Guarulhos 2
Ipatinga 2
Johannesburg 2
Maringá 2
Montreal 2
Nuremberg 2
Panama City 2
Philadelphia 2
Recife 2
Redmond 2
Ribeirão Preto 2
Salto 2
Salvador 2
Simi Valley 2
Totale 3.686
Salva come PNG Salva come JPEG
Nome #
Recombinant galectin-1 prevents experimental colitis in mice via T cell apoptosis. 168
An NO-derivative of acetaminophen, NCX-701, spares the liver by inhibiting Fas-dependent apoptosis 103
GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice 100
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. 99
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. 95
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity 94
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 92
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. 90
A nitro-arginine derivative of trimebutine (NO2-Arg-Trim) attenuates pain induced by colorectal distension in conscious rats. 86
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. 83
5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. 79
Antiatherosclerotic effect of farnesoid X receptor. 79
Activation of FXR Improves Myocardial Fatty Acid Metabolism in a Rodent Model of Liver Steatosis 79
A beta-oxidation-resistant lipoxin A(4) analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction 77
An essential role of Farnesoid X-Receptor in regulating intestinal fibrosis in murine model of chronic colitis 77
Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages. 76
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 73
Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. 71
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension 71
Counter-regulatory role of bile acid activated receptors in immunity andinflammation. 70
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 70
a Farnesoid-X-Receptor (FXR)-Glucocorticoid Receptor (GR) Cascade Regulates Intestinal Innate Immunity in Response to FXR Activation 69
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 69
4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity. 68
Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation 67
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. 66
Proteinase activated receptor (PAR)-2 protects against colitis in mice. Evidence for direct modulation of lamina propria T lymphocytes. 66
Cardiac safety and antitumoral activity of a new nitric oxide derivative of pegylated epirubicin in mice. 65
The HIV Matrix Protein p17 subverts Nuclear Receptors Expression and induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes 65
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatorybowel diseases and arthritis 65
Nitric oxide protects againist HIV gp 120 endothelial injury. 65
The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease. 64
Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin. 64
The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis. 63
Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA 63
Proteinase activated receptor (PAR)-2 agonistic peptide protects from Th-1 mediated liver injury in mice. 63
Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis. 63
The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice. 62
Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. 62
Farnesoid X receptor suppresses constitutive androstane receptoractivity at the multidrug resistance protein-4 promoter. 61
FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents. 61
Role of the FXR in Regulating Bile Acid Homeostasis and Relevance for Human Diseases 60
Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. 60
Critical role of toll-like receptors in modulating GM-CSF activity in rodent models of colitis 60
NCX-1000, an NO derivative of UDCA, releases NO and protects against portal hypertension by inhibiting hepatic stellate cell contraction. 59
A hydrogen-sulfide releasing derivative of mesalamine exhibits markedly enhanced anti-inflammatory effects in experimental colitis 59
The nuclear receptor FXR regulates hepatic transport and metabolism of glutamine and glutamate 58
Inhibition of NF-κB by a PXR-dependent pathwaymediates counter-regulatory activities of rifaximin on innate immunity inintestinal epithelial cells. 57
COX-2 selective inhibitors cause gastric damage in aspirin treated rats. Protective effect of nitroaspirin (NCX-4016). 57
Mechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neurons 57
IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs. 56
The third gas: H2S regulates perfusion pressure in both theisolated and perfused normal rat liver and in cirrhosis. 56
Gene Expression Changes Induced by HIPEC in a Murine Model of Gastric Cancer 54
The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. 54
Epigenetic modulation by methionine deficiency attenuates the potential for gastric cancer cell dissemination. 54
VLA-1 immunoneutralization protects against colon damage in a mouse model of colitis 53
Nitric oxide modulates proapoptotic and antiapoptotic properties of chemotherapy agents: the case of NO-pegylated epirubicin. 52
Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis. 52
Targetting farnesoid-X-receptor: from medicinal chemistry to disease treatment. 52
FXR an emerging therapeutic target for the treatment of atherosclerosis. 51
In vivo administration of ritonavir worsens intestinal damage caused by cyclooxygease inhibitors. 51
A Novel Source of Intestinal Damage: The HIV Protease Inhibitor Ritonavir Worsens Damage Caused by COX Inhibitors 51
Hydrogen sulphide induces micro opioid receptor-dependent analgesia in a rodent model of visceral pain. 50
SHP-dependent and -independent induction of peroxisomeproliferator-activated receptor-γ by the bile acid sensor farnesoid X receptorcounter-regulates the pro-inflammatory phenotype of liver myofibroblasts. 50
FXR Activation Reverses Insulin Resistance and Protects Against NASH Development 50
NCX-999, a NO-releasing derivative of UDCA, modulates hepatic stellate cells and reduces vasomotor response to nor-epinefrine in intact rats 50
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination. 50
The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats. 49
Inhibition of hydrogen sulfide generation contributes to gastric injury caused byanti-inflammatory nonsteroidal drugs. 49
Farnesoid-X-receptor (FXR) ligands induce a small heterodimer partner (SHP)-dependent upregulation of PPAR-gamma in hepatic stellate cells and in rat model of liver fibrosis. 49
The bile acid receptor FXR is a modulator of intestinal innate immunity. 49
Different sensitivity of lamina propria T-cell subsets to nitric oxide-induced apoptosis explains immunomodulatory activity of a nitric oxidereleasing derivative of mesalamine in rodent colitis. 48
Instruction of Intestinal Microbiota by VSL#3 Reverses NASH and Accelerated Atherosclerosis Caused by Intestinal Inflammation in ApoE(-/-) Mice 48
H2S Induces Analgesia Is Mediated In Vivo Activation of mu Opioid Receptor and PI3K/AKT Pathway Activation 48
The CCR5 Antagonist Maraviroc Reduces the Potential for Gastric Cancer Dissemination in Rodent Models of Peritoneal Metastasis 47
Protective effects of granulocyte macrophage colony stimulating factor (gm-Csf) in Hapten-induced colitis 46
The nuclear receptor SHP (small heterodimer partner) mediates inhibitory effects of farnesoid-X-receptor (FXR) on hepatic stellate cells and protects against liver fibrosis in rodents. 46
Co-administration of nitric oxide-aspirin (NCX-4016) andaspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans. 45
Impaired calcineurin signaling in myeloid cells results in downregulation of pentraxin-3 and increased susceptibility to aspergillosis 45
Essential Role of DNAX Adaptor Protein 12 (DAP12) and Spleen Tyrosine Kinase (Syk) in Inflammation-Driven Immune Dysfunction in Rodent Model of Colitis 44
Total synthesis and pharmacological characterization of solomonsterol A, a potent marine pregnane-X-receptor agonist endowed with anti-inflammatory activity. 43
Solomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis. 43
Molecular Determinants of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in a Model of Peritoneal Gastric Cancer Carcinogenesis 40
Celecoxib exacerbates gastrointestinal damage induced by aspirin but not by NO-aspirin (NCX-4016): A randomised, parallel group, blind-observer endoscopic study. Evidence for a protective role of NO in the gastrointestinal mucosa 40
Role of Maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced 40
Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome. 40
‘The Farnesoid X Receptor Promotes Adipocyte Differentiationd regulates adipose cell function in vivo’ 39
The Nuclear Receptor SHP Mediates Inhibition of Hepatic Stellate Cells by FXR and Protects Against Liver Fibrosis 39
Heat shock proteins as key biological targets of the marine natural cyclopeptide perthamide 38
Enhanced anti-inflammatory activity of hydrogen sulfide releasing derivative of mesalamine in rodent models of colitis, involves direct inhibition of Nf-kappa B 38
The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation 38
The bile acid sensor FXR regulates insulin transcription and secretion. 37
The Farnesoid X Receptor Promotes Adipocyte Differentiation and Regulates Adipose Cell Function in Vivo 36
The Bile Acid Receptor TGR5 Maintains Gastrointestinal Homeostasis and Its Activation Rescues From Gastrointestinal Injury Caused by ASA and NSAIDs 36
VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation. 34
Inhibition of NF-kB by a PXR-Dependent Pathway Mediates Counter-regulatory Activities of Rifaximin on Innate Immunity in Intestinal Epithelial Cells 34
Gastrointestinal safety and anti-inflammatory activity of HCT-1026, NO-releasing flurbiprofen, in healthy humans volunteers 33
Plakilactones from the Marine Sponge Plakinastrella mamillaris. Discovery of a New Class of Marine Ligands of Peroxisome Proliferator-Activated Receptor gamma 33
Modification of Intestinal Microbiota by VSL#3 Protects Against Development of Pain in the Neonatal Maternal Separation Model. a Whole Genome Array Investigation 32
FXR Activation Corrects Immune-Dysfunction and Attenuates Inflammation in a Rodent Model of Hepatitis 31
Totale 5.893
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.770
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202017 0 0 0 0 0 0 0 0 0 0 0 17
2020/2021884 3 78 41 91 253 37 50 8 74 20 70 159
2021/2022877 15 152 9 32 32 120 5 274 4 8 75 151
2022/20231.563 116 295 8 154 114 173 1 84 556 0 50 12
2023/2024509 35 67 36 4 4 4 109 36 32 17 104 61
2024/20251.310 10 117 53 46 212 49 28 88 252 76 221 158
Totale 5.893